Latest
Flotetuzumab Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Thymoglobulin as GVHD Prophylaxis in AML Conditioning Regimens
Higher Rates of Sustained MRD Negativity Seen With Daratumumab-Containing Regimens Versus SOC in R/R Multiple Myeloma
Fibrin-Specific Nanogels May Improve Result in Disseminated Intravascular Coagulation
Fractionated Gemtuzumab Ozogamicin Not Linked With Increased VOD/SOS Risk in Acute Myeloid Leukemia
FDA Issues Guidance on Coagulation Systems to Measure Viscoelasticity During COVID-19 Pandemic
Bleeding Disorders: What Your Patients Need to Know
Prophylactic Anticoagulation Reduces Risk of 30-Day Mortality in COVID-19
Quality of Life Stable With Daratumumab Plus Bortezomib and Dexamethasone
Mortality Risk After Ischemic Stroke According to Immigration Status and Ethnicity
Stem Cell Transplantation Increases Mortality Risk From COVID-19, Study Confirms
Analysis of the Prognostic Value of the Fibrinogen-Albumin Ratio Index
Featured Content
-
Clinical Management of Malignant Infantile Osteopetrosis
Investigators discussed their clinical approaches to the diagnosis and management of malignant infantile osteopetrosis, as well as the management of long-term posttrasnplant complications. -
Address Possible Security Lapses as Your Practice Returns to Normal
To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks. -
Hairy Cell Leukemia and Hairy Cell Variant: BSH Updates in Diagnosis and Management
The British Society for Haematology released an updated guideline, listing recommendations for the diagnosis and management of hairy cell leukemia and hairy cell variant. -
Curbing Inherent Bias When Caring for Patients
Bias extends beyond skin color to the assumptions physicians might make about patients. -
Burkitt Lymphoma: Clinical, Pathologic, and Genomic Features in Adults
Experts discuss clinical, pathologic, and genomic features of Burkitt lymphoma in adults, as well as standard and emerging treatment options for this patient population. -
Cyclic Thrombocytopenia: Diagnostic and Therapeutic Strategies for a Challenging Condition
Researchers from the Medical University of Vienna highlight diagnostic and management strategies for the treatment of cyclic thrombocytopenia. -
ASH 2020 Coverage
News Coverage from the ASH 2020 Virtual Meeting. -
Current State and Future Directions for Treating NPM1-Mutated Acute Myeloid Leukemia
Investigators addressed challenges associated with the biology, diagnosis, and current state of treatment for patients with NPM1-mutated AML. -
Current Treatment Options for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
-
Loading...
-
Loading...
